Key statistics
On Tuesday, Vericel Corp (ATQP:DUS) closed at 37.00, 28.47% above the 52 week low of 28.80 set on Oct 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 36.80 |
---|---|
High | 37.40 |
Low | 36.80 |
Bid | 37.40 |
Offer | 38.00 |
Previous close | 37.60 |
Average volume | 0.00 |
---|---|
Shares outstanding | 49.03m |
Free float | 48.58m |
P/E (TTM) | 2,171.34 |
Market cap | 2.01bn USD |
EPS (TTM) | 0.0189 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 18:31 BST.
More ▼
Announcements
- Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
- Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
- Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
- Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
- Vericel Reports Second Quarter 2024 Financial Results
- Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
- Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
- Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
- Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
- Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
More ▼